Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Passage BIO, Inc. (PASG)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Sep-30-21Jun-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-Q10-Q
Operating expenses:          
Research and development  17.316.817.715.426.826.226.633.1
Acquired in-process research and development       1.5  
General and administrative  8.119.010.610.713.015.115.015.4
    Loss from operations  -25.4-35.9-28.2-27.5-39.8-42.8-47.1-48.5
Other income (expense), net  1.51.5  0.30.0  
    Net loss  -23.9-34.3-27.1-26.7-39.5-42.8-46.9-48.4
   
Per share information:          
Net loss per share of common stock, basic  ($0.44)($0.63)($0.49)($0.49)($0.73)($0.79)($0.87)($0.90)
Net loss per share of common stock, diluted  ($0.44)($0.63)($0.49)($0.49)($0.73)($0.79)($0.87)($0.90)
   
Weighted average common shares outstanding, basic  54.754.654.454.554.454.354.053.9
Weighted average common shares outstanding, diluted  54.754.654.454.554.454.354.053.9
   
Comprehensive loss:          
Net loss  -23.9-34.3-27.1-26.7-39.5-42.8-46.9-48.4
Unrealized gain (loss) on marketable securities  0.10.50.50.1-0.2-0.90.00.0
    Comprehensive loss  -23.8-33.8-26.6-26.6-39.8-43.7-46.9-48.4

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy